Technical Analysis for ADDXF - Addex Pharms Ltd Ord

Grade Last Price % Change Price Change
B 1.65 0.00% 0.0000
ADDXF closed unchanged on Thursday, May 13, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical ADDXF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Older End-of-Day Signals for ADDXF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Addex Pharms Ltd Ord Description

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.


Classification

Keywords: Drugs Biopharmaceutical Pharmaceutical Products Organic Compounds Chemical Compounds Stage Biopharmaceutical Parkinson's Disease Addiction Epilepsy Disorders Eneva Treatment Of Parkinson's Disease Adx Dyskinesia Dystonia Allosteric Modulator L Dopa Levodopa Induced Dyskinesia Parkinson's Disease Levodopa Induced Dyskinesia

Is ADDXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 1.65
52 Week Low 1.65
Average Volume 2,000
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.6500
Resistance 3 (R3) 1.6500 1.6500 1.6500
Resistance 2 (R2) 1.6500 1.6500 1.6500 1.6500
Resistance 1 (R1) 1.6500 1.6500 1.6500 1.6500 1.6500
Pivot Point 1.6500 1.6500 1.6500 1.6500 1.6500
Support 1 (S1) 1.6500 1.6500 1.6500 1.6500 1.6500
Support 2 (S2) 1.6500 1.6500 1.6500 1.6500
Support 3 (S3) 1.6500 1.6500 1.6500
Support 4 (S4) 1.6500